Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Commissioner Choices Appear To Be Crawford Or Long Wait

Executive Summary

Changes in FDA's political leadership appear to be a low priority for the returning Bush Administration

You may also be interested in...



FDA Nominee Is Crawford: Choice Emphasizes Continuity, Cooperation

The Bush Administration's announcement that it intends to nominate Lester Crawford to be permanent FDA commissioner means that the pharmaceutical industry can count on continuity heading into the renewal process for the prescription drug user fee program

FDA Nominee Is Crawford: Choice Emphasizes Continuity, Cooperation

The Bush Administration's announcement that it intends to nominate Lester Crawford to be permanent FDA commissioner means that the pharmaceutical industry can count on continuity heading into the renewal process for the prescription drug user fee program

FDA, CMS Changes Likely After Thompson Departs; Opening For Rx Imports?

The resignation of HHS Secretary Tommy Thompson creates a new opening for advocates of prescription drug importation in 2005

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel